September 13, 2019
Catalyst backs from offering common stock shares
Catalyst Pharmaceuticals, said Friday it will not conclude the offering of shares of its common stock announced on Wednesday, September…
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
September 13, 2019
Sygnature Discovery relocates to a pharma biotec hub in Boston
Sygnature Discovery has moved its US office to the heart of the Cambridge–Boston biotech hub, describing it as a small but a significant move, as it will have more than 100 pharma/biotech companies within a mile of the new office, and many more in the wider Boston–Cambridge area.
September 13, 2019
BioPharma Credit in new investment deal
BioPharma Credit, the specialist life sciences debt investor, is in a senior secured note purchase agreement for the issuance and sale of senior secured notes in an aggregate original principal amount of up to $150 million by OptiNose US, Inc. alongside BioPharma Credit Investments, a private fund also investing in life sciences debt managed by Pharmakon Advisors launched in June 2019.
September 13, 2019
Anokion Presents New Data Describing Transformative Therapeutic Approach for Treatment of Multiple Sclerosis at ECTRIMS Congress
Induction of Antigen-Specific Immune Tolerance Using Proprietary Technology Represents Novel, Targeted Treatment Modality for Autoimmune Diseases CAMBRIDGE, Mass. & LAUSANNE,…
September 13, 2019
Genentech Presents New Six-year Ocrevus (Ocrelizumab) Data Which Showed That Earlier Initiation and Continuation of Treatment Reduced Disability Progression in Multiple Sclerosis
– Post-hoc analysis from a Phase III open-label extension study showed a 42% reduction in the risk of PPMS patients…
September 13, 2019
PanTheryx Announces Dr. Mehmet Oz to Join its Board of Directors
MD and Emmy award-winning talk show host “Dr. Oz” will help advise biotechnology company focused on innovative bovine colostrum-based therapies…
September 13, 2019
LivaNova to Present Updates on Autonomic Regulation Therapy at the 23rd Annual Scientific Meeting of the Heart Failure Society of America
LONDON–(BUSINESS WIRE)–$LIVN–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it will present a summary of implantable…
September 13, 2019
LivaNova to Present Updates on Autonomic Regulation Therapy at the 23rd Annual Scientific Meeting of the Heart Failure Society of America
LONDON–(BUSINESS WIRE)–$LIVN–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it will present a summary of implantable…
September 13, 2019
Genentech’s Fixed Dose Subcutaneous Combination of Perjeta and Herceptin Showed Non-Inferiority When Compared to Intravenous Formulations for People With HER2-Positive Breast Cancer
– New fixed-dose combination is administered under the skin in just minutes, significantly reducing the time spent receiving treatment –…
September 13, 2019
Third Coast Therapeutics CEO Selected as One of Crain’s Chicago Business’ Notable Entrepreneurs
CHICAGO–(BUSINESS WIRE)–Third Coast Therapeutics, a biotechnology company dedicated to developing orally active, small-molecule drugs, is pleased to announce its chief…